Concourse Financial Group Securities, Inc. Harmony Biosciences Holdings, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.67 Billion
  • Q4 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$31.86 - $41.49 $0 - $0
0 New
0 $0
Q3 2024

Oct 10, 2024
BUY
$30.0 - $39.95 $0 - $0
0 New
0 $0
Q2 2024

Jul 23, 2024
BUY
$28.81 - $33.01 $0 - $0
0 New
0 $0
Q1 2024

Apr 30, 2024
BUY
$29.93 - $35.06 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
$19.2 - $33.78 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$31.89 - $39.03 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
SELL
$31.89 - $39.03 $510 - $624
-16 Closed
0 $0
Q2 2023

Aug 10, 2023
BUY
$30.5 - $37.4 $396 - $486
13 Added 433.33%
16 $0
Q1 2023

May 15, 2023
SELL
$30.8 - $53.92 $277 - $485
-9 Reduced 75.0%
3 $0
Q4 2022

Jan 30, 2023
BUY
$45.4 - $60.91 $544 - $730
12 New
12 $0
Q3 2022

Nov 15, 2022
BUY
$42.06 - $55.45 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$33.54 - $52.15 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$33.14 - $51.13 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$34.09 - $43.91 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$25.68 - $38.61 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$25.96 - $33.44 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$27.56 - $40.37 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$31.74 - $51.34 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$30.96 - $44.39 $0 - $0
0 New
0 $0

Others Institutions Holding HRMY

# of Institutions
255
Shares Held
46.7M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.09B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email